|
Gender, male
|
0.036
|
0.587
|
0.044
|
0.509
|
|
Age (years)
|
−0.051
|
0.441
|
0.083
|
0.214
|
|
BMI (kg/m2)
|
0.077
|
0.247
|
0.063
|
0.344
|
|
WHR
|
−0.094
|
0.157
|
−0.044
|
0.515
|
|
Place of residence
|
−0.160
|
0.016
|
−0.110
|
0.100
|
|
Marital status
|
−0.037
|
0.578
|
−0.018
|
0.788
|
|
Education
|
0.099
|
0.140
|
0.065
|
0.331
|
|
Employment status
|
−0.008
|
0.907
|
0.035
|
0.599
|
|
Income/year
|
0.113
|
0.090
|
0.068
|
0.311
|
|
Medical insurance, yes
|
0.009
|
0.894
|
−0.043
|
0.525
|
|
Comorbidities
|
|
Hypertension
|
−0.138
|
0.038
|
−0.033
|
0.621
|
|
DM
|
−0.140
|
0.036
|
−0.079
|
0.238
|
|
Hyperlipidemia
|
−0.005
|
0.941
|
0.031
|
0.643
|
|
Cardiovascular disease
|
−0.194
|
0.003
|
−0.182
|
0.006
|
|
Nephropathy
|
−0.018
|
0.785
|
−0.012
|
0.855
|
|
Disease duration (year)
|
−0.198
|
0.003
|
−0.066
|
0.324
|
|
Number of flares/last year
|
−0.292
|
<0.001
|
−0.174
|
0.009
|
|
Stage of gout
|
−0.066
|
0.322
|
−0.060
|
0.367
|
|
Total pain (VAS)
|
−0.349
|
<0.001
|
−0.251
|
<0.001
|
|
Number of tophi
|
−0.233
|
<0.001
|
−0.159
|
0.017
|
|
UA (μmol/L)
|
−0.083
|
0.216
|
−0.100
|
0.133
|
|
Presence of tender joints, yes
|
−0.175
|
0.008
|
−0.243
|
<0.001
|
|
Presence of swollen joints, yes
|
−0.108
|
0.105
|
−0.130
|
0.051
|
|
Urate lowering therapy
|
|
Allopurinol
|
0.087
|
0.192
|
0.107
|
0.107
|
|
Febuxostat
|
0.049
|
0.467
|
0.005
|
0.942
|
|
Any anti-inflammatory drugs
|
|
Colchicine
|
−0.157
|
0.018
|
−0.159
|
0.017
|
|
NSAID
|
−0.006
|
0.925
|
−0.025
|
0.712
|
|
Corticosteroids
|
−0.156
|
0.019
|
−0.228
|
0.001
|
|
Depression (PHQ-9 ≥ 10 score)
|
−0.366
|
<0.001
|
−0.407
|
<0.001
|
|
Anxiety (GAD-7 ≥ 10 score)
|
−0.195
|
<0.001
|
−0.290
|
<0.001
|
